191 related articles for article (PubMed ID: 25668207)
1. Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.
Kim JH; Ko YJ; Kim JY; Oh Y; Hwang J; Han S; Kim S; Lee JH; Han DH
PLoS One; 2015; 10(2):e0118084. PubMed ID: 25668207
[TBL] [Abstract][Full Text] [Related]
2. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
3. Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.
Lee KH; Kim SH; Kim CH; Min BJ; Kim GJ; Lim Y; Kim HS; Ahn KM; Kim JH
J Transl Med; 2019 Nov; 17(1):381. PubMed ID: 31747953
[TBL] [Abstract][Full Text] [Related]
4. Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw.
Polidoro S; Broccoletti R; Campanella G; Di Gaetano C; Menegatti E; Scoletta M; Lerda E; Matullo G; Vineis P; Berardi D; Scully C; Arduino PG
Mutat Res; 2013 Oct; 757(2):104-13. PubMed ID: 23892139
[TBL] [Abstract][Full Text] [Related]
5. SIRT1/HERC4 Locus Associated With Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysis.
Yang G; Hamadeh IS; Katz J; Riva A; Lakatos P; Balla B; Kosa J; Vaszilko M; Pelliccioni GA; Davis N; Langaee TY; Moreb JS; Gong Y
J Bone Miner Res; 2018 Jan; 33(1):91-98. PubMed ID: 28856724
[TBL] [Abstract][Full Text] [Related]
6. Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis.
Wehrhan F; Moebius P; Amann K; Ries J; Preidl R; Neukam FW; Weber M
J Craniomaxillofac Surg; 2017 Jun; 45(6):944-953. PubMed ID: 28365078
[TBL] [Abstract][Full Text] [Related]
7. Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
Thumbigere-Math V; Michalowicz BS; Hughes PJ; Basi DL; Tsai ML; Swenson KK; Rockwell L; Gopalakrishnan R
J Oral Maxillofac Surg; 2016 Apr; 74(4):738-46. PubMed ID: 26501428
[TBL] [Abstract][Full Text] [Related]
8. Genetic association between VEGF polymorphisms and BRONJ in the Korean population.
Choi H; Lee JH; Kim HJ; Park W; Lee JH; Kim JH
Oral Dis; 2015 Oct; 21(7):866-71. PubMed ID: 26086871
[TBL] [Abstract][Full Text] [Related]
9. Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw.
Thumbigere-Math V; Michalowicz BS; de Jong EP; Griffin TJ; Basi DL; Hughes PJ; Tsai ML; Swenson KK; Rockwell L; Gopalakrishnan R
Oral Dis; 2015 Jan; 21(1):46-56. PubMed ID: 24286378
[TBL] [Abstract][Full Text] [Related]
10. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.
Bodem JP; Kargus S; Eckstein S; Saure D; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2015 May; 43(4):510-4. PubMed ID: 25841311
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
[TBL] [Abstract][Full Text] [Related]
12. Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3.
Nicoletti P; Cartsos VM; Palaska PK; Shen Y; Floratos A; Zavras AI
Oncologist; 2012; 17(2):279-87. PubMed ID: 22267851
[TBL] [Abstract][Full Text] [Related]
13. Current management concepts for bisphosphonate-related osteonecrosis of the jaw: a review.
Kilic E; Doganay O
Gen Dent; 2018; 66(6):e1-e5. PubMed ID: 30444713
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
15. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
[TBL] [Abstract][Full Text] [Related]
16. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
[TBL] [Abstract][Full Text] [Related]
20. Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw.
de Lima PB; Brasil VL; de Castro JF; de Moraes Ramos-Perez FM; Alves FA; dos Anjos Pontual ML; da Cruz Perez DE
Support Care Cancer; 2015 Dec; 23(12):3421-6. PubMed ID: 25757408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
